Enovix price target lowered to $21 from $22 at Canaccord

Canaccord analyst George Gianarikas lowered the firm’s price target on Enovix (ENVX) to $21 from $22 and keeps a Buy rating on the shares. The firm noted the quarter introduced another delay in the “hockey stick” P&L they have been anticipating and tell investors to continue to be patient.

Meet Your ETF AI Analyst

Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on ENVX:

Disclaimer & DisclosureReport an Issue

Enovix price target lowered to $21 from $22 at Canaccord Enovix’s Strategic Partnership with Honor: A Buy Rating Amidst Challenges and Opportunities Enovix Corporation Reports Strong Q3 2025 Results Enovix sees Q4 non-GAAP EPS (16c)-(20c), consensus (14c) Enovix reports Q3 EPS (14c), consensus (16c)

View Comments